YoungSolvers Webinar: From Fragment to Drug Candidate with SeeSAR

webinar

Tue, 13 Jul 2021, 14:00 CEST (Berlin)

Alexander Neumann

YoungSolvers Webinar: From Fragment to Drug Candidate with SeeSAR

In this workshop you will learn how to evolve a small fragment to a full-fledged lead compound. We will cover the main aspects of structure-based modeling with the platform SeeSAR, including free energy approximations, conformational analysis, fragment growing, and many more. The workshop provides interactive insights into chemical properties, hypothesis testing, and the decision-making process. Furthermore, you will learn how to create meaningful graphics at publication quality level.

Level: Beginner

Current news

category
Challenge
Winner of Fall 2021 Scientific Challenge: Aaron Kuriakose Prakash with Covalent Tuberculosis Drugs
September 20, 2022 12:56 CEST
We are excited to announce the winner of the Fall 2021 Scientific Challenge: Aaron Kuriakose Prakash from the Madras Christian College (Chennai, India)! In the past twelve months he used the covalent docking feature of SeeSAR to screen for potential drug candidates to treat tuberculosis infections. He got the best...
Read on
category
Software
Introducing eXplore — a New Trillion-Sized Chemical Space by eMolecules
September 12, 2022 13:06 CEST
eXplore – the largest commercial Chemical Space featuring over 2.8 trillion tangible compounds is now available. Created jointly with eMolecules, the Chemical Space was designed to provide users with accessible compounds to match their needs during a drug discovery project. eXplore has been created with a selection of eMolecules’s building...
Read on
category
Events
Recap Drugathon 2022
July 13, 2022 13:10 CEST
The first BioSolveIT Drugathon has concluded and the feedback is overwhelming. Over 400 people from around the globe have registered to this unique drug discovery event where research from around the globe collaborate on a single target structure to design novel compounds. The group of Prof. Anna Hirsch volunteered to...
Read on